Oncology & Cancer

Study may explain why once-promising cancer drugs failed

Nearly two decades after a class of once-promising cancer drugs called MMP inhibitors mysteriously failed in clinical trials, scientists think they may have an explanation for what went wrong.

Oncology & Cancer

Pushing closer to a new cancer-fighting strategy

A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

Parkinson's & Movement disorders

New evidence sheds light on how Parkinson's disease may happen

Researchers at Baylor College of Medicine and Texas Children's Hospital have identified unexpected new key players in the development of an early onset form of Parkinson's disease called Parkinsonism. These key players are ...

page 14 from 40